Menstrual Dysfunction in Girls From the Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Study

Overview

Journal J Clin Endocrinol Metab

Publisher Oxford University Press

Specialty Endocrinology

Date 2018 Apr 27

PMID 29697830

Citations 7

Authors

Megan M Kelsey

Barbara H Braffett

Mitchell E Geffner

Lynne L Levitsky

Sonia Caprio

Siripoom V McKay

Rachana Shah

Jennifer E Sprague

Silva A Arslanian

Affiliations

Soon will be listed here.

Abstract

Context: Little is known about reproductive function in girls with youth-onset type 2 diabetes.

Objectives: To characterize girls with irregular menses and effects of glycemic treatments on menses and sex steroids in the Treatment Options for Type 2 Diabetes in Youth (TODAY) study.

Design: Differences in demographic, metabolic, and hormonal characteristics between regular- vs irregular-menses groups were tested; treatment group (metformin with or without rosiglitazone, metformin plus lifestyle) effect on menses and sex steroids over time in the study was assessed. This is a secondary analysis of TODAY data.

Setting: Multicenter study in an academic setting.

Patients: TODAY girls not receiving hormonal contraception and those at least 1-year postmenarche were included. Irregular menses was defined as three or fewer periods in the prior 6 months.

Results: Of eligible participants with serum measurement of sex steroids (n = 190; mean age, 14 years), 21% had irregular menses. Those with irregular vs regular menses had higher body mass index (BMI) (P = 0.001), aspartate aminotransferase (AST) (P = 0.001), free androgen index (P = 0.0003), and total testosterone (P = 0.01) and lower sex hormone-binding globulin (SHBG) (P = 0.004) and estradiol (P = 0.01). Differences remained after adjustment for BMI. There was no treatment group effect on menses or sex steroids at 12 or 24 months, and no association of sex steroids was seen with measures of insulin sensitivity or secretion.

Conclusions: Menstrual dysfunction is common in girls with recently diagnosed type 2 diabetes and associated with alterations in sex steroids, SHBG, and AST but not with alteration in insulin sensitivity or β-cell function and did not improve with 2 years of antihyperglycemic treatment.

Citing Articles

Type 2 diabetes in children and adolescents: Exploring the disease heterogeneity and research gaps to optimum management.

Pramanik S, Mondal S, Palui R, Ray S World J Clin Pediatr. 2024; 13(2):91587.

PMID: 38947996 PMC: 11212753. DOI: 10.5409/wjcp.v13.i2.91587.

Prevalence of polycystic ovary syndrome in patients with type 2 diabetes: A systematic review and meta-analysis.

Long C, Feng H, Duan W, Chen X, Zhao Y, Lan Y Front Endocrinol (Lausanne). 2022; 13:980405.

PMID: 36120432 PMC: 9471325. DOI: 10.3389/fendo.2022.980405.

Females with Diabetes Mellitus Increased the Incidence of Premenstrual Syndrome.

Huang Y, Chien W, Cheng C, Chang Y, Chung C, Cheng C Life (Basel). 2022; 12(6).

PMID: 35743808 PMC: 9224876. DOI: 10.3390/life12060777.

Prevalence and risk factors of chronic complications among patients with type 2 diabetes mellitus in Morocco: a cross-sectional study.

El Alami H, Haddou I, Benaadi G, Lkhider M, El Habchi D, Wakrim L Pan Afr Med J. 2022; 41:182.

PMID: 35655685 PMC: 9120751. DOI: 10.11604/pamj.2022.41.182.25532.

Spectrum of Phenotypes and Causes of Type 2 Diabetes in Children.

Shah A, Nadeau K, Dabelea D, Redondo M Annu Rev Med. 2022; 73:501-515.

PMID: 35084995 PMC: 9022328. DOI: 10.1146/annurev-med-042120-012033.

References

Escalante Pulido J, Alpizar Salazar M . Changes in insulin sensitivity, secretion and glucose effectiveness during menstrual cycle. Arch Med Res. 1999; 30(1):19-22. DOI: 10.1016/s0188-0128(98)00008-6. View

Baillargeon J, Jakubowicz D, Iuorno M, Jakubowicz S, Nestler J . Effects of metformin and rosiglitazone, alone and in combination, in nonobese women with polycystic ovary syndrome and normal indices of insulin sensitivity. Fertil Steril. 2004; 82(4):893-902. DOI: 10.1016/j.fertnstert.2004.02.127. View

Liao L, Tian Y, Zhao J, Xin Y, Xing H, Dong J . Metformin versus metformin plus rosiglitazone in women with polycystic ovary syndrome. Chin Med J (Engl). 2011; 124(5):714-8. View

Uwaifo G, Fallon E, Chin J, Elberg J, Parikh S, Yanovski J . Indices of insulin action, disposal, and secretion derived from fasting samples and clamps in normal glucose-tolerant black and white children. Diabetes Care. 2002; 25(11):2081-7. DOI: 10.2337/diacare.25.11.2081. View

Cucinelli F, Paparella P, Soranna L, Barini A, Cinque B, Mancuso S . Differential effect of transdermal estrogen plus progestagen replacement therapy on insulin metabolism in postmenopausal women: relation to their insulinemic secretion. Eur J Endocrinol. 1999; 140(3):215-23. DOI: 10.1530/eje.0.1400215. View

Van Pelt R, Gozansky W, Schwartz R, Kohrt W . Intravenous estrogens increase insulin clearance and action in postmenopausal women. Am J Physiol Endocrinol Metab. 2003; 285(2):E311-7. PMC: 2819703. DOI: 10.1152/ajpendo.00490.2002. View

Sjaarda L, Bacha F, Lee S, Tfayli H, Andreatta E, Arslanian S . Oral disposition index in obese youth from normal to prediabetes to diabetes: relationship to clamp disposition index. J Pediatr. 2012; 161(1):51-7. PMC: 3366166. DOI: 10.1016/j.jpeds.2011.12.050. View

Radivojevic T, Anselmi J, Scalas E . Ergodic transition in a simple model of the continuous double auction. PLoS One. 2014; 9(2):e88095. PMC: 3928121. DOI: 10.1371/journal.pone.0088095. View

Hillman J, Miller R, Inge T . Menstrual concerns and intrauterine contraception among adolescent bariatric surgery patients. J Womens Health (Larchmt). 2011; 20(4):533-8. PMC: 3075047. DOI: 10.1089/jwh.2010.2462. View

10.

Dunaif A . Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev. 1997; 18(6):774-800. DOI: 10.1210/edrv.18.6.0318. View

11.

Jensen M, Martin M, Cryer P, Roust L . Effects of estrogen on free fatty acid metabolism in humans. Am J Physiol. 1994; 266(6 Pt 1):E914-20. DOI: 10.1152/ajpendo.1994.266.6.E914. View

12.

Rosenfield R, Bordini B . Evidence that obesity and androgens have independent and opposing effects on gonadotropin production from puberty to maturity. Brain Res. 2010; 1364:186-97. PMC: 2992573. DOI: 10.1016/j.brainres.2010.08.088. View

13.

VOLLMAN R . The menstrual cycle. Major Probl Obstet Gynecol. 1977; 7:1-193. View

14.

Moran L, Misso M, Wild R, Norman R . Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update. 2010; 16(4):347-63. DOI: 10.1093/humupd/dmq001. View

15.

Legro R, Lin H, Demers L, Lloyd T . Rapid maturation of the reproductive axis during perimenarche independent of body composition. J Clin Endocrinol Metab. 2000; 85(3):1021-5. DOI: 10.1210/jcem.85.3.6423. View

16.

Espeland M, Hogan P, FINEBERG S, Howard G, Schrott H, Waclawiw M . Effect of postmenopausal hormone therapy on glucose and insulin concentrations. PEPI Investigators. Postmenopausal Estrogen/Progestin Interventions. Diabetes Care. 1998; 21(10):1589-95. DOI: 10.2337/diacare.21.10.1589. View

17.

Blank S, Helm K, McCartney C, Marshall J . Polycystic ovary syndrome in adolescence. Ann N Y Acad Sci. 2008; 1135:76-84. DOI: 10.1196/annals.1429.005. View

18.

Hartz A, Barboriak P, Wong A, Katayama K, Rimm A . The association of obesity with infertility and related menstural abnormalities in women. Int J Obes. 1979; 3(1):57-73. View

19.

Campbell S, Febbraio M . Effect of the ovarian hormones on GLUT4 expression and contraction-stimulated glucose uptake. Am J Physiol Endocrinol Metab. 2002; 282(5):E1139-46. DOI: 10.1152/ajpendo.00184.2001. View

20.

George L, Bacha F, Lee S, Tfayli H, Andreatta E, Arslanian S . Surrogate estimates of insulin sensitivity in obese youth along the spectrum of glucose tolerance from normal to prediabetes to diabetes. J Clin Endocrinol Metab. 2011; 96(7):2136-45. PMC: 3205514. DOI: 10.1210/jc.2010-2813. View